CoChat

BDNF-induced LTP is associated with rapid Arc/Arg3.1-dependent enhancement in adult hippocampal neurogenesis

Open access

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Abstract

Adult neurogenesis in the hippocampus is a remarkable phenomenon involved in various aspects of learning and memory as well as disease pathophysiology. Brain-derived neurotrophic factor (BDNF) represents a major player in the regulation of this unique form of neuroplasticity, yet the mechanisms underlying its pro-neurogenic actions remain unclear. Here, we examined the effects associated with brief (25 min), unilateral infusion of BDNF in the rat dentate gyrus. Acute BDNF infusion induced long-term potentiation (LTP) of medial perforant path-evoked synaptic transmission and, concomitantly, enhanced hippocampal neurogenesis bilaterally, reflected by increased dentate gyrus BrdU + cell numbers. Importantly, inhibition of activity-regulated cytoskeleton-associated protein (Arc/Arg3.1) translation through local, unilateral infusion of anti-sense oligodeoxynucleotides (ArcAS) prior to BDNF infusion blocked both BDNF-LTP induction and the associated pro-neurogenic effects. Notably, basal rates of proliferation and newborn cell survival were unaltered in homozygous Arc/Arg3.1 knockout mice. Taken together these findings link the pro-neurogenic effects of acute BDNF infusion to induction of Arc/Arg3.1-dependent LTP in the adult rodent dentate gyrus.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep21222

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Schematic representation illustrating the sequence of events comprising the experimental setup. IdU (230 mg/kg; i.p.) and BrdU (200 mg/kg; i.p.) were administered 24 and 4 hours, respectively, prior to sacrifice to time-stamp hippocampal newborn cells that underwent division. After a 20 min baseline, BDNF (or Cytochrome C) was infused, 20 minutes following BrdU administration, for 25 minutes at a speed of 80 nl/min. Subsequent BDNF-induced LTP was monitored and recorded for 195 minutes, before animals were sacrificed and tissue was collected for histological analysis. Arc/Arg3.1 antisense oligodeoxynucleotides (Arc AS) or Arc/Arg3.1 scrambled oligodeoxynucleotides (Arc ASScr) were administered 90 minutes prior to BDNF infusion for 12.5 minutes at a rate of 80 nl/min to inhibit Arc/Arg3.1 translation and block BDNF-induced LTP.
Figure 1 Schematic representation illustrating the sequence of events comprising the experimental setup. IdU (230 mg/kg; i.p.) and BrdU (200 mg/kg; i.p.) were administered 24 and 4 hours, respectively, prior to sacrifice to time-stamp hippocampal newborn cells that underwent division. After a 20 min baseline, BDNF (or Cytochrome C) was infused, 20 minutes following BrdU administration, for 25 minutes at a speed of 80 nl/min. Subsequent BDNF-induced LTP was monitored and recorded for 195 minutes, before animals were sacrificed and tissue was collected for histological analysis. Arc/Arg3.1 antisense oligodeoxynucleotides (Arc AS) or Arc/Arg3.1 scrambled oligodeoxynucleotides (Arc ASScr) were administered 90 minutes prior to BDNF infusion for 12.5 minutes at a rate of 80 nl/min to inhibit Arc/Arg3.1 translation and block BDNF-induced LTP.CC BY · PubMed Central
Figure 2 Time-course plot illustrating changes in perforant path-DG evoked fEPSP slope expressed in percentage of baseline. Values are means ± SEM. CytC, BDNF, BDNF+ArcAS and BDNF+Arc ASScr infusion points are indicated. Average field potential traces (10 sweeps) collected at the end of baseline and during the recording (post-BDNF) phases are shown. Calibration: 5 mV, 2 ms. (n = 8/9 per group). Representative photomicrographs illustrating NeuN and Arc/Arg3.1 expression changes in the DG following unilateral BDNF infusion (BDNF-infused) or unilateral CytC infusion (CytC-infused).
Figure 2 Time-course plot illustrating changes in perforant path-DG evoked fEPSP slope expressed in percentage of baseline. Values are means ± SEM. CytC, BDNF, BDNF+ArcAS and BDNF+Arc ASScr infusion points are indicated. Average field potential traces (10 sweeps) collected at the end of baseline and during the recording (post-BDNF) phases are shown. Calibration: 5 mV, 2 ms. (n = 8/9 per group). Representative photomicrographs illustrating NeuN and Arc/Arg3.1 expression changes in the DG following unilateral BDNF infusion (BDNF-infused) or unilateral CytC infusion (CytC-infused).CC BY · PubMed Central
Figure 3 Total IdU+ and BrdU+ cells. Representative photomicrographs illustrating IdU immunohistochemistry in the dentate gyrus following BDNF infusion (a, 4× magnification; b, 10× magnification). Since the monoclonal anti-IdU antibody used here could not discriminate between IdU or BrdU, it labeled all dividing IdU+ and/or BrdU+ cells. Total numbers of IdU-labeled cells thus represent a combination of three distinct cell populations: IdU+/BrdU−, IdU−/BrdU+ and IdU+/BrdU+ cells. Graph illustrating average total numbers of total labeled cells in the hippocampal hilus, subgranular zone (SGZ) and granule cell layer (GCL) per group (n = 8/9) ± SEM (c). Graphs illustrating average numbers of labeled cells in the stimulated (BDNF-infused, d) and contralateral hemisphere (e). The * and $ symbols represent significant effects compared to CytC- or BDNF-treated animals, respectively. One, two or three symbols represent p < 0.05, p < 0.01, p < 0.001, respectively.
Figure 3 Total IdU+ and BrdU+ cells. Representative photomicrographs illustrating IdU immunohistochemistry in the dentate gyrus following BDNF infusion (a, 4× magnification; b, 10× magnification). Since the monoclonal anti-IdU antibody used here could not discriminate between IdU or BrdU, it labeled all dividing IdU+ and/or BrdU+ cells. Total numbers of IdU-labeled cells thus represent a combination of three distinct cell populations: IdU+/BrdU−, IdU−/BrdU+ and IdU+/BrdU+ cells. Graph illustrating average total numbers of total labeled cells in the hippocampal hilus, subgranular zone (SGZ) and granule cell layer (GCL) per group (n = 8/9) ± SEM (c). Graphs illustrating average numbers of labeled cells in the stimulated (BDNF-infused, d) and contralateral hemisphere (e). The * and $ symbols represent significant effects compared to CytC- or BDNF-treated animals, respectively. One, two or three symbols represent p < 0.05, p < 0.01, p < 0.001, respectively.CC BY · PubMed Central
Figure 4 Representative confocal photomicrographs depicting triple immunofluorescent BrdU/Arc/NeuN and double BrdU/IdU labeling from an animal receiving BDNF infusion. Photomicrographs illustrating both BrdU+/Arc+/NeuN+and BrdU+/Arc−/NeUN+ cells (a–d). High magnification images of inserts (e), illustrating a BrdU+/Arc+/NeuN+ cell (e1–e4,f) showing a BrdU+/NeUN+ cell negative for Arc (f1–f4). The latter images demonstrate that although Arc seems ubiquitously expressed in the DG, some IdU+ and/or BrdU+ cells were clearly Arc negative. Representative confocal photomicrographs depicting two different proliferating cells positive for BrdU and/or IdU (g–k): the first cell is clearly double positive for IdU and BrdU (j,j1) while the second is only positive for IdU (k,k1).
Figure 4 Representative confocal photomicrographs depicting triple immunofluorescent BrdU/Arc/NeuN and double BrdU/IdU labeling from an animal receiving BDNF infusion. Photomicrographs illustrating both BrdU+/Arc+/NeuN+and BrdU+/Arc−/NeUN+ cells (a–d). High magnification images of inserts (e), illustrating a BrdU+/Arc+/NeuN+ cell (e1–e4,f) showing a BrdU+/NeUN+ cell negative for Arc (f1–f4). The latter images demonstrate that although Arc seems ubiquitously expressed in the DG, some IdU+ and/or BrdU+ cells were clearly Arc negative. Representative confocal photomicrographs depicting two different proliferating cells positive for BrdU and/or IdU (g–k): the first cell is clearly double positive for IdU and BrdU (j,j1) while the second is only positive for IdU (k,k1).CC BY · PubMed Central
Figure 5 Graphs illustrating average total numbers of BrdU+(IdU−/BrdU+ and IdU+/BrdU+) cells in the hippocampal hilus, subgranular zone (SGZ) and granule cell layer (GCL) per group (n = 8/9) ± SEM (a) as well as average numbers of BrdU+ cells in the stimulated (BDNF-infused, b) and contralateral hemisphere (c). Graphs illustrating averages of total numbers of IdU(only)+ or IdU+/BrdU- cells in the hippocampal hilus, subgranular zone (SGZ) and granule cell layer (GCL) per group (n = 8/9) ± SEM (d) as well as average numbers of IdU(only)+ cells in the stimulated (BDNF-infused, e) and contralateral hemisphere (f). The * and + symbols represent significant effects compared to CytC- or BDNF-treated animals, respectively. One, two or three symbols represent p < 0.05, p < 0.01, p < 0.001, respectively.
Figure 5 Graphs illustrating average total numbers of BrdU+(IdU−/BrdU+ and IdU+/BrdU+) cells in the hippocampal hilus, subgranular zone (SGZ) and granule cell layer (GCL) per group (n = 8/9) ± SEM (a) as well as average numbers of BrdU+ cells in the stimulated (BDNF-infused, b) and contralateral hemisphere (c). Graphs illustrating averages of total numbers of IdU(only)+ or IdU+/BrdU- cells in the hippocampal hilus, subgranular zone (SGZ) and granule cell layer (GCL) per group (n = 8/9) ± SEM (d) as well as average numbers of IdU(only)+ cells in the stimulated (BDNF-infused, e) and contralateral hemisphere (f). The * and + symbols represent significant effects compared to CytC- or BDNF-treated animals, respectively. One, two or three symbols represent p < 0.05, p < 0.01, p < 0.001, respectively.CC BY · PubMed Central
Figure 6 Graphs illustrating average total numbers of IdU−/BrdU+/Arc+ (IdU−/BrdU+/Arc+and IdU+/BrdU+/Arc+) cells in the hippocampal hilus, subgranular zone (SGZ) and granule cell layer (GCL) per group (n = 8/9) ± SEM (a) as well as average numbers of BrdU+/Arc+ cells in the stimulated (BDNF-infused, b) and contralateral hemisphere (c). Graphs illustrating average total numbers of BrdU+/Arc− (IdU−/BrdU + /Arc− and IdU+/BrdU+/Arc−) cells in the hippocampal hilus, subgranular zone (SGZ) and granule cell layer (GCL) per group (n = 8/9) ± SEM (d) as well as average numbers of BrdU+/Arc− cells in the stimulated (BDNF-infused, e) and contralateral hemisphere (f). The * and + symbols represent significant effects compared to CytC− or BDNF-treated animals, respectively. One, two or three symbols represent p < 0.05, p < 0.01, p < 0.001, respectively.
Figure 6 Graphs illustrating average total numbers of IdU−/BrdU+/Arc+ (IdU−/BrdU+/Arc+and IdU+/BrdU+/Arc+) cells in the hippocampal hilus, subgranular zone (SGZ) and granule cell layer (GCL) per group (n = 8/9) ± SEM (a) as well as average numbers of BrdU+/Arc+ cells in the stimulated (BDNF-infused, b) and contralateral hemisphere (c). Graphs illustrating average total numbers of BrdU+/Arc− (IdU−/BrdU + /Arc− and IdU+/BrdU+/Arc−) cells in the hippocampal hilus, subgranular zone (SGZ) and granule cell layer (GCL) per group (n = 8/9) ± SEM (d) as well as average numbers of BrdU+/Arc− cells in the stimulated (BDNF-infused, e) and contralateral hemisphere (f). The * and + symbols represent significant effects compared to CytC− or BDNF-treated animals, respectively. One, two or three symbols represent p < 0.05, p < 0.01, p < 0.001, respectively.CC BY · PubMed Central
Figure 7 Graphs illustrating average total numbers of IdU+/BrdU−/Arc+ cells in the hippocampal hilus, subgranular zone (SGZ) and granule cell layer (GCL) per group (n = 8/9) ± SEM (a) as well as average numbers of IdU+/BrdU−/Arc+ cells in the stimulated (BDNF-infused, b) and contralateral hemisphere (c). Graphs illustrating average total numbers of IdU+/BrdU-/Arc- cells in the hippocampal hilus, subgranular zone (SGZ) and granule cell layer (GCL) per group (n = 8/9) ± SEM (d) as well as average numbers of IdU+/BrdU-/Arc- cells in the stimulated (BDNF-infused, e) and contralateral hemisphere (f). The * and + symbols represent significant effects compared to CytC- or BDNF-treated animals, respectively. One, two or three symbols represent p < 0.05, p < 0.01, p < 0.001, respectively.
Figure 7 Graphs illustrating average total numbers of IdU+/BrdU−/Arc+ cells in the hippocampal hilus, subgranular zone (SGZ) and granule cell layer (GCL) per group (n = 8/9) ± SEM (a) as well as average numbers of IdU+/BrdU−/Arc+ cells in the stimulated (BDNF-infused, b) and contralateral hemisphere (c). Graphs illustrating average total numbers of IdU+/BrdU-/Arc- cells in the hippocampal hilus, subgranular zone (SGZ) and granule cell layer (GCL) per group (n = 8/9) ± SEM (d) as well as average numbers of IdU+/BrdU-/Arc- cells in the stimulated (BDNF-infused, e) and contralateral hemisphere (f). The * and + symbols represent significant effects compared to CytC- or BDNF-treated animals, respectively. One, two or three symbols represent p < 0.05, p < 0.01, p < 0.001, respectively.CC BY · PubMed Central
Figure 8 Total BrdU-labeled cells in Arc/Arg3.1-deficient and wild-type mice. Representative photomicrographs illustrating BrdU immunohistochemistry in the DG of wild-type and Arc/Arg3.1-deficient mice 24 hours and 28 days following BrdU administration (8a–d). Graph illustrating average total numbers of BrdU-labeled cells ± SEM in the hippocampal hilus, subgranular zone (SGZ) and granule cell layer (GCL) of wild-type mice and Arc/Arg3.1-deficient mice sacrificed 24 hours and 28 days after BrdU administration, respectively (n = 6) (8e).
Figure 8 Total BrdU-labeled cells in Arc/Arg3.1-deficient and wild-type mice. Representative photomicrographs illustrating BrdU immunohistochemistry in the DG of wild-type and Arc/Arg3.1-deficient mice 24 hours and 28 days following BrdU administration (8a–d). Graph illustrating average total numbers of BrdU-labeled cells ± SEM in the hippocampal hilus, subgranular zone (SGZ) and granule cell layer (GCL) of wild-type mice and Arc/Arg3.1-deficient mice sacrificed 24 hours and 28 days after BrdU administration, respectively (n = 6) (8e).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 50 references

Cited by

See all 84

Metadata

Authors
Kuipers, S. D., Trentani, A., Tiron, A., Mao, X., Kuhl, D., & Bramham, C. R.
Affiliations
  • University of Bergen (NO)
  • University Medical Center Hamburg-Eppendorf (DE)
Corresponding author
Kuipers, Sjoukje D.
Venue
Scientific Reports
Published
2016-02-18
Volume
6
Issue
1
Pages
21222-21222
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2299866425
Cited by
83
References
49
Citations by year
2026: 6 · 2025: 3 · 2024: 8 · 2023: 4 · 2022: 9 · 2021: 10 · 2020: 10 · 2019: 12 · 2018: 4 · 2017: 14 · 2016: 3
FWCI
5.63
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • NORA - Norwegian Open Research Archives (submittedVersion, cc-by)
Funders
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek
  • Universitetet i Bergen
  • Norges Forskningsråd
Topics
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
Keywords
brain-derived neurotrophic factor, long-term potentiation, adult hippocampal neurogenesis, Arc/Arg3.1, dentate gyrus, neuroplasticity, BrdU labeling
MeSH terms
Animals, Cytoskeletal Proteins, Evoked Potentials, Male, Nerve Tissue Proteins, Synaptic Transmission, Rats, Sprague-Dawley, Long-Term Potentiation, Dentate Gyrus, Brain-Derived Neurotrophic Factor, Rats, Neurogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: BDNF-induced LTP is associated with rapid Arc/Arg3.1-dependent enhancement in adult hippocampal neurogenesis. https://app.cochat.ai/papers/10.1038/srep21222
The paper
Kuipers, S. D., Trentani, A., Tiron, A., Mao, X., Kuhl, D., & Bramham, C. R. (2016). BDNF-induced LTP is associated with rapid Arc/Arg3.1-dependent enhancement in adult hippocampal neurogenesis. Scientific Reports. https://doi.org/10.1038/srep21222

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.